Introduction
Inflammatory bowel diseases, Crohn's disease (CD) and ulcerative colitis (UC), represent chronic inflammation of the gastrointestinal tract of unknown aetiology involving immunological events. Recently, these immunological parameters have been described as secondary but may possibly be attributed to the chronicity of the disease.
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Research on the aetiopathogenesis of inflammatory bowel disease and testing of potential therapeutic agents has been hampered by the (Fig. 6 ). LTB 4 production by incubated gut sections from treated animals was reduced more markedly by oral than by intraluminal SAZ or 5-ASA treatment (Fig. 7A ). Oral treatment (Fig. 7) resulted in a 60% or 50% reduction (Fig. 7B ). 
